Good Therapeutics lands $8M to develop protein drugs that work only where needed in the body

Good Therapeutics, a Seattle startup, has raised $8 million toward advancing therapeutic proteins aimed at helping cancer patients.

With 22 employees total, the company is currently selecting a clinical candidate for its IL-2 program which has been showing promising results.